retatrutide facts A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity | European Journal of Clinical Pharmacology Demand for Unapproved Weight-Loss Drug

Retatrutide clinical trial doses range from 2 mg (starting) to 12 mg (maximum maintenance), administered once weekly by subcutaneous injection (Jastreboff et al., NEJM 2023)

Experimental and Therapeutic Medicine

187 Grape seed extract exerts antioxidation against ferroptosis and reduces calcium and iron levels in high fat-fed mice

How to Read a GHRH-Analog Study Because so much confusion in the tesamorelin vs sermorelin discussion comes from mismatched comparisons, a few reading habits help: Identify the population

Excellent for those wanting to shred fat effectively, these shots pair well with a balanced diet and routine exercise

Different weight loss medications demonstrate varying gastrointestinal side effect profiles, which can inform treatment selection for patients particularly concerned about diarrhea